Injection/Infusion
SOLIQUA SOLUTION FOR INJECTION IN A PRE-FILLED PEN 100 UNITS/ML + 50 MICROGRAMS/ML
Summary
SOLIQUA SOLUTION FOR INJECTION IN A PRE-FILLED PEN 100 UNITS/ML + 50 MICROGRAMS/ML — Injection/Infusion containing insulin glargine, lixisenatide. Hong Kong Registration No. HK-65638. Certificate Holder: SANOFI HONG KONG LIMITED. Date of Registration: 06 Mar, 2018.
Product NameSOLIQUA SOLUTION FOR INJECTION IN A PRE-FILLED PEN 100 UNITS/ML + 50 MICROGRAMS/ML
Registration No.HK-65638
Certificate HolderSANOFI HONG KONG LIMITED
Holder Address1/F & SECTION 212 ON 2/F, AXA SOUTHSIDE, 38, WONG CHUK HANG ROAD, WONG CHUK HANG, HONG KONG
Ingredientsinsulin glargine, lixisenatide
Dosage FormInjection/Infusion
Legal ClassificationPart 1, Schedule 1 & Schedule 3 Poison
Sale RequirementPrescription only Medicines
Date of Registration06 Mar, 2018
ATC codesA10AE04, A10BJ03
ATC Classification
ATC level 1
A Alimentary Tract and Metabolism
All ATC groupsA10
This product contains more than one active ingredient. The ATC groups above describe the ingredients, not a single category for the product as a whole.
本頁為藥物資料查詢工具，並非藥物廣告、推廣或醫療建議。所有資料取自香港特別行政區衞生署藥物辦公室之公開資料，僅供參考；一切以藥物辦公室官方公布為準。 本頁不提供任何療效、適應症或治療用途之陳述。用藥前請諮詢醫生或註冊藥劑師。 本網站遵守香港法例第 231 章《不良廣告（醫藥）條例》之規管。